SCHEMBL3095457

SCHEMBL3095457

COC(=O)c1ncn2c1CN(S(=O)(=O)c1c(C)cc(OC)cc1C)CC2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
PKM P14618 4/20 0.38
KMT2A Q03164 3/20 0.37
MEN1 O00255 1/20 0.37
MAPK1 P28482 1/20 0.37
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
NPC1 O15118 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPSR1 Q6W5P4 1/20 0.34
CYP3A4 P08684 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3082544 0.90 KMT2A (0.37) PKMKMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL3724021 0.82 KMT2A (0.36) PKMKMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL3096506 0.78 CYP3A4 (0.52) KMT2AMAPK1SMN1; SMN2ALDH1A1CYP3A4
SCHEMBL3088274 0.71 KMT2A (0.37) PKMKMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL3088638 0.70 KMT2A (0.44) KMT2AMEN1MAPK1ALDH1A1KDM4E
SCHEMBL15062702 0.69 KMT2A (0.36) PKMKMT2AMEN1MAPK1SMN1; SMN2
SCHEMBL3079208 0.69 AKR1C3 (0.52) POLBPKMKMT2AMEN1SMN1; SMN2
SCHEMBL14411560 0.68 PKM (0.59) PKMKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL3084311 0.68 POLB (0.46) POLBALDH1A1L3MBTL1NPSR1
SCHEMBL3087962 0.65 ALDH1A1 (0.39) POLBSMN1; SMN2ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2393812-B1 SUBSTITUTED SPIROAMIDES AS B1R-MODULATORS GRUENENTHAL GMBH (DE) 2013-07-03 EP disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 US disclosed
EP-2393812-A1 SUBSTITUTED SPIRO-AMIDES AS B1R MODULATORS Grünenthal GmbH (DE) 2011-12-14 EP disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 US disclosed
WO-2010089127-A1 SUBSTITUTED SPIRO-AMIDES AS B1R MODULATORS Grünenthal GmbH (DE) 2010-08-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B POLB 3022/4885PKM 1620/4885KMT2A 2897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.